From established players to up-and-coming firms, Canada's pharmaceutical company landscape is diverse and dynamic. Canadian ...

Numiera Therapeutics Inc., a client company of Fort Collins-based Innosphere and a pharmaceutical pioneer in small-molecule ...

A subsidiary of a Miami-based company is inching closer to FDA approval for a drug that treats a rare pediatric disease.

Nuvalent's NVL-655 and Zidesamtinib show strong potential as first-line therapies for NSCLC. Click here to find out why I ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

LAS VEGAS, NV / ACCESSWIRE / / Alyea Therapeutics Corporation Inc. ("Alyea" or the "Company"), a subsidiary of Alt 5 Sigma Corporation (NASDAQ:ALTS), announced today its engagement in key events ...

By adding Canada and the entire Latin America region, including Mexico, WODA completes its full global commercialization offering for rare and ...

The latest announcement is out from GeneTether Therapeutics, Inc. ( ($TSE:GTTX) ). Rize Oncology, formerly GeneTether Therapeutics, has announced ...

Rigel Pharmaceuticals (RIGL) announced that the U.S. Food and Drug Administration has granted Orphan Drug designation to R289 for the treatment ...

Rigel Pharmaceuticals on Thursday said the U.S. Food and Drug Administration granted orphan-drug designation to its proposed R289 treatment for myelodysplastic syndromes, a group of rare blood cancers ...

(Alliance News) - PureTech Health PLC on Thursday said that the US Food & Drug Administration has granted fast track designation to its antibody LYT-200 for the treatment of acute myeloid leukemia.